Nasdaq-listed Leap Therapeutics buys 203K ZEC, rebrands
November 12, 2025, 12:12 PM
Nasdaq-listed Leap Therapeutics (LPTX) has initiated a strategic investment in ZEC. As part of this move, the company purchased 203,000 ZEC and has changed its name to Cypherpunk Technologies.
Log in to leave comments!
Share insights, connect ideas
Log In
